Wearable Injectors market is projected to rise over a CAGR of 24.53% wearable injectors market

Global wearable injectors market is expected to reach a
value of US$ 13.0 Bn by 2024
According
to
a
market
report
published
by
BlueWeave
Consulting
(www.blueweaveconsulting.com), The Global wearable injectors market is
expected to reach a value of US$ 13.0 Bn by 2024, owing to growing burden of
geriatric population, increasing prevalence of chronic diseases, high demand for
advanced drug delivery and increasing compliance for controlled drug delivery.
The emerging economies offer ample growth opportunities for the global of wearable
injectors market. However, alternative drug delivery methods hinder the growth of the
global market. The market is projected to expand at a CAGR of 23.0% during the forecast
period from 2018 to 2024 by value.
Accelerating pervasiveness of chronic diseases is driving the market growth
The demand for wearable injectors is increasing due to increasing prevalence of chronic and
lifestyle associated diseases. The prevalence of chronic diseases, such as heart disease,
cancer, stroke, and diabetes, is increasing due to the alteration in lifestyle and lack of
access to preventive care. As reported by WHO in 2014, there were 422 million adults
suffering from diabetes. Eastern Mediterranean region had the highest prevalence of
diabetes (13.7%) in 2014, followed by South-East Asia (8.6%). According to Centre for
Disease Control and Prevention (CDC), approximately 117 million people in 2012 in the U.S.
had one or more chronic health conditions.
Request
for
PDF
Sample
of
this
Market
Research
https://www.blueweaveconsulting.com/wearable-injectors-market#ReportSample
1
Report@